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Purpose: Transvenous inferior vena cava (IVC) filters are used successfiflly for prevention 
of pulmonary embolism (PE), but early thrombotic omplications such as insertion site 
thrombosis (IST) and inferior vena cava thrombosis (IVCT) may occur after placement. 
The frequency of these complications has been uncertain particularly for the wide variety 
of newer devices. This study was performed to prospectively evaluate IST and IVCT with 
color-flow venous duplex ultrasound scanning after four IVC filters were placed: the birds' 
nest filter, the titanium Greenfield filter, the stainless teel Greenfield filter, and the Simon 
nitinol filter. 
Methods: Percutaneous IVC filters were placed in 174 patients over a 21-month period. A 
birds' nest filter was used in 39 (22%) cases, a titanium Greenfield filter in 67 (39%) cases, 
a stainless teel Greenfield filter (25%) in 43 patients, and a Simon nitinol filter in 25 (14%) 
cases. Filters were placed for major deep venous thrombosis n 113 (63%) patients, after PE 
in 26 (15%) patients, and with prophylaxis n35 (20%) patients. All patients had color-flow 
venous duplex ultrasound scanning of the insertion site and the inferior vena cava 7 to 10 
days after placement or before discharge to document IST or VCT. 
Results: Early IST occurred in 43 (24.7%) cases, and early IVCT was observed in 20 (12%) 
cases in this series. No significant difference was found in the incidence of IST or IVCT 
among the four filter types used. The incidence of IVCT was significantly higher in patients 
having filters placed for PE. Men were more likely to receive a prophylactic filter than 
women in this study, but thrombotic omplications were not related to patient sex. 
Thrombosis was seen with equal frequency at all insertion sites used. No patient died of 
PE after filter placement during the study period. 
Conclusions: The incidence of thrombotic complications for all devices was higher than has 
generally been reported. No IVC filter used in this study demonstrated superior 
performance with regard to these thrombotic omplications. As vena cava interruption 
devices are developed or significantly modified, prospective objective analysis of associated 
thrombotic omplications will allow logical selection for clinical use. (J Vase Surg 
1996;24:809-18.) 
Pulmonary embolism (PE) causes more than 
100,000 deaths per year in the United States despite 
heightened awareness of high-risk patient groups and 
increased attention to prophylaxis for venous throm- 
boembolism. 1,2 Most patients with deep venous 
thrombosis (DVT), PE, or both can be treated with 
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standard anticoagulant therapy. However, when there 
is a contraindication to anticoagulation, a complica- 
tion of its use, or a failure of standard therapy to 
control the thromboembolic process, mechanical in- 
terruption of the inferior vena cava (IVC) has been 
recommended. 3-~The primary goal of vena caval 
interruption is prevention of (fatal) PE. A secondary 
goal is to maintain patency of the IVC ,  because 
patients who have inferior vena caval thrombosis 
(IVCT) after these procedures have been observed 
to have a higher incidence of chronic venous dys- 
function. 6-8 
Surgical techniques for vena caval interruption 
had significant morbidity and mortality 8-1° and were 
reserved for patients who had already had pulmonary 
embolism. These procedures were also associated 
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with IVC thrombosis in more than 60% of cases. 9
Transvenous caval interruption devices like the 
Mobin-Uddin umbrella 11 reduced the morbidity of 
IVC interruption but were still associated with IVC 
thrombosis in most of the cases. The introduction i
1972 of the Kimray-Greenfield filter marked asignifi- 
cant advancement i  this field, combining successful 
prevention of PE with clearly superior IVC patency. 
Since the first follow-up report was published in 
1977,12 caval patency rates of 92% to 98% s,13,14 have 
been reported for the Greenfield filter, and PE has 
been observed in only 1% to 4% of cases. 1~,16 The 
Greenfield filter has become the most widely used 
device for caval interruption and serves as a standard 
with which newer devices have been compared. 
Another milestone in the evolution of these tech- 
niques was the  development of percutaneous filter 
insertion. 17 This development eliminated the need for 
surgical exposure of the femoral or jugular veins, but 
initial reports also noted femoral venous insertion site 
thrombosis (IST) in up to 41% of cases. 18 Neverthe- 
less the safety and efficacy of percutaneous trans- 
venous IVC interruption has led to an increasing- 
liberalization of the clinical indications for filter place- 
ment. Now patients with DVT alone (not PE) are 
routinely considered for filter placement. Even pro- 
phylactic placement of an IVC filter has been recom- 
mended in some high-risk cases uch as patients with 
trauma in whom fatal thromboembolic complications 
have been observed espite aggressive DVT prophy- 
laxis.19, 2°
The number of devices available for caval inter- 
ruption has dramatically increased. This increase has 
included the bird's nest filter (BNF), 21 the Simon- 
nitinol filter (NF), 22 the Hunter balloon, 23 the 
Gunther filter, 24 and the Vena-tech filterY Even the 
Greenfield filter has undergone a change in its struc- 
tural materials and modification of its design since the 
original introduction. 26Overall, the selection of a 
given device has often been determined more by 
familiarity or convenience rather than by documented 
performance. With an increasing number of patients 
being treated and devices available, it becomes essen- 
tial to critically examine the efficacy and safety of these 
interventions. 
Initial studies of IVC filters 27 were compromised 
by the number of patients available for follow-up 
study and the need for contrast cavography for the 
determination fcaval patency. In this regard venous 
duplex ultrasound scanning (VDS) represents an- 
other milestone in the evolution of vena caval inter- 
ruption devices. VDS has a diagnostic accuracy equal 
to that of contrast venography for the detection of 
major axial DVT 28 in the lower extremities. Techno- 
logic modifications have allowed routine deep ab- 
dominal duplex scanning including diagnostic evalu- 
ation of the IVC. 29 VDS has eliminated the risks and 
discomfort of venography and allows simultaneous 
evaluation of the IVC and the insertion site after a 
filter is placed. This study was performed to prospec- 
tively evaluate IVC patency and insertion site throm- 
bosis with VDS after placement of four types of IVC 
filters used in our institution: the BNF, the NF, the 
titanium Greenfield filter (TGF), and the stainless 
steel Greenfield filter (SGF). 
METHODS 
Vena cava filters were placed in 235 patients at the 
University of Maryland Hospital and the Maryland 
Shock-Trauma Institute during a 21-month study 
period from March 1994 through December 1995. 
Postprocedural color-flow VDS was performed in 
174 cases (74% of all filters placed), and these cases 
form the basis of this report. The study group 
consisted of 74 women and 100 men whose ages 
ranged from 16 to 90 years (mean age 55 years). 
Table I lists the indication for filter placement in this 
study. Major DVT alone led to filter placement in 113 
(64.9%) patients, and pulmonary embolism was the 
indication in 26 (14.9%) cases, in both instances most 
often in patients with a contraindication to anticoagu- 
lant therapy. Prophylactic filters were placed in 35 
(20.1%) patients who were believed to be at prohibi- 
tive risk for venous thromboembolism. 
All patients had filter insertion performed with a 
percutaneous technique under fluoroscopic guidance 
in an interventional radiology suite. Filters were 
inserted through the tight femoral vein in i26 
(72.4%) cases, through the left femoral vein in 37 
(21.3%) cases, or through the jugular vein in 11 
(6.3%) patients. All patients underwent cavography 
before filter insertion to measure the size of the vena 
cava and to obtain information regarding location of 
the renal veins, congenital anomalies, and the pres- 
ence of in situ vena caval thrombus. Selection of filter 
type and the site of insertion was not randomized or 
controlled and was at the discretion of the physicians 
performing the procedure; no attempt was made to 
influence their customary selection process. The only 
selection bias observed was that BNFs were placed 
routinely when an IVC greater than 28 mm in 
transverse diameter was identified by cavography. One 
of our commercially available filters were inserted as 
summarized inTable II: the Gianturco-Roehm bird's 
nest filter (BNF, N = 39) (Cook Co., Bloomington, 
Ind.), the titanium Greenfield filter (TGF, N = 67) 
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Table I. Indications for IVC filter placement 
in patients in the study 
Table II. Distribution ofvena caval filter 
types used in this study 
Indication Total Percent Filter Total Percent 
DVT 113 64.9 BNF 39 22.4 
PE 26 14.9 TGF 67 38.5 
Prophylaxis 35 20.i SGF 43 24.7 
Total 174 NF 25 14.4 
Total 174 
PE, Pulmonary embolism both with contraindicarion/compli- 
cation/failure of anticoagulant therapy. Prophylactic filters were 
inserted in selective patients at high-risk (predominantly trauma) 
without diagnosis of thromboembolic complications. 
with modified hook design (Medi-tech Inc., Water- 
town, Mass.), the stainless teel Greenfield filter (SGF, 
N =43) with 12F introducer system (Medi-tech, 
Inc., Watertown, Mass.), found the Simon-nitinol 
filter (NF, N=25)  (Bard Radiology, Covington, 
Ga.). Plain radiographs were obtained to check filter 
position after insertion in each case. No patients 
received full systemic anticoagulant therapy immedi- 
ately after filter placement, but this study was not 
controlled for the use of low-dose heparin or inter- 
mittent mechanical compression devices, which were 
used for DVT prophylaxis in many patients. After 
thrombotic complications (IST, IVCT) were de- 
tected during the study period, treatment was at the 
discretion of the managing physicians. 
All patients in the study had venous duplex scan- 
ning of the venous insertion site and the vena cava to 
diagnose acute IST to assess IVC patency. In most 
cases VDS was performed within the first 7 to 10 days 
after insertion, but all scans were performed before 
discharge. The occurrence of thrombotic omplica- 
tions in these patients was compared for different filter 
types, the indications for filter placement, he sex of 
the patient, and the site of insertion. Occurrences in
different groups were compared with Z 2 analysis, with 
a p value <0.05 indicating statistical significance. 
VDS. Examination of the inferior vena cava was 
performed with a variety of commercially available 
duplex scanners from a single manufacturer (Ad- 
vanced Technologies Laboratories, Bothel, Wash.). 
Low-frequency abdominal transducers were used, 
and patients were examined after overnight fasting. 
Imaging planes included both sagittal and transverse 
views, and Doppler examination was performed with 
the longitudinal view. Vcna caval duplex scanning 
began in the midline at the umbilicus where the 
iliocaval confluence was identified, and the examina- 
tion proceeded cephalad to identify the filter. The 
echogenicity of the filter will vary depending on the 
type of filter placed. The proximal segment of the 
Greenfield filter (the most frequently used filter) 
appears bullet-shaped, whereas the distal portion 
should have its struts visualized along the caval wall 
(Fig. 1). Direct visualization of echogenic filling 
defects will be possible in most cases of acute caval 
thrombosis (Fig. 2). Compressibility (one of the 
duplex scan criteria for diagnosis of acute DVT in 
extremity veins) is limited in the vena cava, and 
Doppler flow evaluation becomes important in ex- 
amination of the IVC. Pulsatile venous Doppler 
signals may be routinely recorded in the normal IVC 
because of the transmission of the cardiac cycle 
retrograde through the major central venous ystem 
as a result of the absence of venous values. This 
pulsatility will diminish below the level of the renal 
veins and will begin to exhibit the typical phasicity 
with respiration that has been observed with normal 
lower extremity Doppler venouS examination. Caval 
thrombus has the same ultrasound characteristics a
seen in lower extremity DVT. However, as noted 
previously, compressibility is limited and is not as 
reliable for diagnostic purposes as in the extremities, 
and direct imaging plays a more important role in the 
diagnosis of caval thrombus. 
Duplex scan evaluation of the femoral or jugular 
vein insertion sites was performed in the standard 
fashion. Acute thrombosis was identified by direct 
visualization of an echogenic filling defect or by 
distension and incompressibility of the venous seg- 
ment with reduced or absent Doppler flow. 
RESULTS 
Duplex ultrasound scanning of the vena cava was 
considered technically satisfactory in 167 (96%) of the 
174 cases in this study, and insertion site scanning was 
diagnostic in all cases. Treatment oflST or IVCT was 
at the discretion of the managing physician(s). During 
the study period 34 (19.5% of study group) patients 
who had filter placement and follow-up VDS died. 
None of these deaths was related to filter insertion or 
was the result of pulmonary embolism. 
IST. Insertion site thrombosis was diagnosed in 
43 (24.7%) of the 174 patients in this study. Table III 
lists the frequency of IST in each filter group. Inser- 
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Fig. 1. Duplex scan of inferior vena cava after insertion of Greenfield filter. Struts of filter can 
be identified as brightly echogenic linear structures along lateral walls oflVC on this sagittal view 
(arrow). 
Fig. 2. Duplex scan diagnosis of 1VC thrombosis after filter insertion. Thrombus appears as 
echogenic filling defect in lumen of IVC similar to ultrasonographic appearance of DVT in 
extremities. 
tion site thrombosis occurred in 17 (25.4%) patients 
having a TGF and in 13 (30.2%) patients in whom an 
SGF was used. Nine (23.1%) patients with a BNF had 
IST, and four (16%) cases of lST were diagnosed after 
insertion of an NF (Fig. 3). A comparison of the 
lowest rate of IST (NF) with the highest (SGF) did 
not indicate any statistically significant difference in 
the incidence of IST in these different filter groups 
(p = 0.16). The incidence of IST was 25.4% (32 of 
126 cases) in the right femoral vein, 24.3% (9 of 37) 
in the left femoral vein, and 18% (2 of11 cases) in the 
jugular vein. No significant difference was seen in the 
rate of IST based on the insertion site used. Insertion 
site thrombosis occurred in 24% of both women (19 
of 74) and men (24 of 100) in this study. Insertion site 
thrombosis occurred in 27.8% of patients with filters 
placed for PE, in 24.8% of patients who had DVT as 
the indication for IVC filter, and in 14.3% of patients 
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Fig. 3. Incidence oflST diagnosed by venous duplex scanning in each offour lVC filter groups 
studied: BNF, TGF, SGF, NF. 
in whom a filter was placed with prophylaxis. No 
statistically significant difference was seen in the 
incidence of IST based on the indication for filter 
placement (p = 0.16). 
IVCT. Venous duplex scanning diagnosed WCT 
in 20 of the 167 cases in which VDS was able to 
successfully examine the vena cava for an overall IVCT 
rate of 12% for this study. Table III lists the occurrence 
of IVCT by filter type. Caval thrombosis occurred in 
5.3% of cases with a BNF, a 12.5% of cases with a TGF, 
in 17.5% of cases with an SGF, andin 12% of cases with 
an NF (Fig. 4). Comparison of the lowest incidence of 
IVCT (BNF) with the highest (SGF) indicated that 
no statistically significant difference was present in the 
rate o f lVCT in the different filter groups (p = 0.09). 
Vena caval thrombosis occurred in 13% of women and 
in 11% of men in this study (p = 0.75). 
Indications for insertion. The indications for 
filter placement in this study have been noted previ- 
ously and are listed in Table I. Vena caval filters were 
placed for major DVT in 68.9% of men and in 62% of 
women in this study. Pulmonary embolism was the 
indication for filter placement in 18.9% of women and 
in 12% of men, but this difference was not significant 
(p= 0.27). Prophylactic filters were placed in 26 
(26%) o f l00  men in this study but in only 9 (12.2%, 
p < 0.05) of 74 women; thus men were significantly 
more likely to receive aprophylactic vena cava filter in 
this study. 
Pulmonary embolism was the indication for place- 
ment in 25.6% of cases of BNF, but PE was the 
indication for insertion in only 4% of cases where the 
NF was placed (p < 0.03). The TGF and SGF were 
placed for PE in 11.9% and 16.3% of cases, respec- 
tively (NSD compared with BNF). Thus overall the 
NF was placed significantly less often in patients with 
PE. No other significant differences were seen in the 
indication for filter placement in the different filter 
groups. 
Among 26 filters placed for PE, caval occlusion 
was observed in 6 (23.1%) cases. Patients having filter 
placement for DVT were observed to have IVCT in 
14 (13.1%) of 107 cases. When prophylactic filter 
placement was performed, no case of  IVCT was seen, 
and all these patients were successfully studied. Over- 
all, the incidence of IVCT was significantly higher in 
patients who had filter insertion for PE than in those 
who had prophylactic filters placed (p < 0.004). The 
incidence of lST was also highest in patients who had 
filters placed for PE (27.8%). However, this rate was 
not statistically significantly higher than the rate of  
IST in patients with filters placed for DVT (24.8%) or 
those who had filters placed with prophylaxis (14.3%). 
Filter type. As noted previously, BNFs were used 
in 22.4% of cases, TGFs in 38.5% of cases, SGFs in 
24.7% of cases, and NFs in 14.4% of cases. Table IV 
lists the filter types used in men and women in this 
study. No statistically significant difference was found 
in the distribution of filters used in either men or 
women in the study group. 
DISCUSSION 
Percutaneous transvenous IVC filters have re- 
duced the risks of caval interruption, and the preven- 
tion of pulmonary embolism by these devices has been 
well documented. Complications of IVC filters such 
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Fig. 4. Incidence of IVCT diagnosed by venous duplex scanning in each of four filter groups 
studied: BNF, TGF, SGF, NF. 
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as malposition, 3° migration, 31 and caval perfora- 
tion ls,18,32 have been only anecdotally reported. The 
frequency of the more common complications such as 
filter insertion site thrombosis and vena caval throm- 
bosis has been variously reported and remains uncer- 
tain, especially for newer devices or recent echno- 
logic changes of traditional devices like the Greenfield 
filter. A single-center p ospective evaluation of these 
thrombotic omplications in multiple filter types has 
not been previously reported. 
Insertion site thrombosis is the most common 
complication reported after filter placement. The 
incidence of lST has ranged from 4% to 41%. 13'27 All 
currently available devices have had their delivery 
system modified or primarily developed to facilitate 
percutaneous insertion, but despite these efforts IST 
has been observed in 5% to 30% of patients after filter 
placement. 16'33 In studies reporting lower rates of 
IST, often only patients with symptoms were studied, 
and routine surveillance for IST was not performed. 
Dorfman et al.34 reported a 14.3% incidence of 
femoral IST after placement ofpercutaneous Green- 
field filters with routine ultrasound scanning. How- 
ever, only one (11%) of nine patients had a symptom- 
atic new DVT. Mewissen et al? 5 prospectively evalu- 
ated insertion sites with ultrasound scanning and 
found IST in 18% of cases. In their study five (56%) of 
nine patients had symptoms. It is clear that when only 
patients with symptoms are studied, the actual rate of 
IST will be significantly underreported. 
The 24.7% incidence of IST in this series is 
probably higher than would have been predicted 
before this study. All filters were placed by experi- 
enced interventional radiologists, and so issues of 
technique alone are probably irrelevant at this time. In 
addition, no significant differences were found in the 
incidence of IST among the four filters used in this 
study. Simon et al?2 reported an IST rate of 27.8% 
with ultrasound scanning in a previous tudy of the 
NF. The rate of IST for the NF was 16%, but 
considering the statistical comparisons with the other 
groups noted previously, it is unlikely that this result 
represents a significant difference from the previous 
report. The design, size, and materials used for any of 
these devices appear to have no identifiable impact (at 
present) on the development of IST after placement. 
Patients requiting IVC interruption are by definition 
at higher isk for venous thromboembolism, and the 
occurrence of IST is in this regard understandable. 
Nevertheless it may be relevant in the future to look 
more carefully at this complication to determine 
whether further modification in materials or tech- 
niques can reduce this complication. 
In the past some have questioned the clinical 
relevance of IST, noting, as previously mentioned, 
that most of these cases are asymptomatic? 4,3s How- 
ever, it is well known that the development of the 
chronic postthrombotic syndrome is related to the 
"burden" of thrombus and to recurrent thrombotic 
events that produce progressive destruction of deep 
venous valves. Furthermore the importance of com- 
mon femoral vein valve function in lower limb venous 
hemodynamics has been emphasized by many inves- 
tigators. Although vena caval thrombosis is more 
likely to predispose to chronic venous dysfunction, it 
is unlikely that new thrombus in the femoral veins 
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Table III. The incidence of IST and IVCT for each of the four filter types tudied uring this period 
Filter Total IST Percent IST IVCT Percent IVCT 
BNF 39 9 23.1 2 5.3 
TGF 67 17 25.7 8 12.5 
SGF 43 13 30.2 7 17.5 
NF 25 4 16 3 12 
Table IV. The distribution of the four different filter types in men and women in this study 
Filter Total Men (N) Men (%) Women (N) Women (%) 
BNF 39 24 23.5 15 20 
TGF 67 38 37.3 29 39.2 
SGF 43 23 22.5 20 27 
NF 26 15 15.7 10 13.5 
induced by filter insertion is clinically irrelevant. The 
issue of IST may be particularly important in patients 
in whom IVC filters have been placed with prophy- 
laxis, because none of these patients was known to 
have DVT before filter placement. The incidence of 
IST was 14.3% in patients having filters placed for 
prophylaxis n this study. 
To avoid concern about insertion site thrombosis, 
it has bcen recommended by some 17'28 that filters 
should be preferentially placed through the jugular 
vein, because ithas been assumed that jugular throm- 
bosis would occur rarely. Jugular vein IST was ob- 
served in 18% of cases in this study, and this result was 
not significantly ower than that seen in either the 
right or left femoral veins. Although the number of 
cases with a jugular insertion site in this series was 
small (N = 11), this observation underscores the fact 
that unless prospective evaluation is performed in all 
cases, the true incidence of these complications i  
uncertain. The risk of PE from jugular vein throm- 
bosis like that of all upper extremity DVT would be 
expected to be low. Nevertheless, unlike femoral vein 
IST, the patient with jugular IST is not protected from 
clot migration by the filter. 
Vena caval thrombosis after IVC filter insertion 
has been a more serious concern than insertion site 
thrombosis. Previous tudies have required invasive 
contrast studies to evaluate vena caval patency and 
have often reported smaller numbers of total patients 
treated. In 1983 Pasto et al.36 first reported the use of 
ultrasound scanning for the evaluation of vena caval 
patency in patients after Kimray-Greenfield filters 
were placed. Caval occlusion was diagnosed by ultra- 
souography and confirmed by venography in 11% of 
patients, very similar to the I2% rate of IVCT diag- 
nosed byVDS in this study. Wingo et al.37 investigated 
the utility of duplex ultrasound scanning to evaluate 
caval patency after insertion of standard Greenfield 
filters. Patency of the IVC was detected in92% of the 
technically adequate duplex studies. Three cases of 
vena caval occlusion were documented byvenacavog- 
raphy, and two were studied and accurately diagnosed 
by duplex examination. Since that time technologic 
modifications in available ultrasound equipment have 
allowed routine deep abdominal duplex scanning, 
and vena caval scanning has been used to characterize 
the ultrasonographic appearance of various filters 29 
and to examine the IVC for thrombosis and other 
disease. 3s 
It can bc seen from this study that VDS provides 
a very useful means for the prospective evaluation of 
thrombotic complications ofIVC filter placement. I  
should be remembered, however, that he accuracy of 
VDS for the diagnosis of caval thrombosis has not 
bccn validated compared with its use for diagnosis of 
lower limb DVT. The diagnostic accuracy of VDS for 
lower limb DVT has been most often criticized for a 
reduced sensitivity, 39with larger numbers of false- 
negative scans compared with venography. If this 
experience were extrapolated to vena caval scanning, 
it would logically suggest that he observed incidence 
oflVC thrombosis diagnosed byVDS was lower than 
the actual rate. When vena caval duplex scanning is 
positive for IVC thrombosis after filter placement, i  
should represent a reasonable baseline stimate of this 
complication suitable for comparisons across groups 
of different devices. A technologically satisfactory 
examination is essential to diagnosis, but with expe- 
rience these examinations can be diagnostic in most 
cases, as was the case in 96% of the patients in this 
study. 
Past studies of the Greenfield filter have reported 
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IVCT rates from 0% to 11%. s'13'16 Because both the 
design and structural materials of the Greenfield filter 
have been changed uring this period, it is certainly 
appropriate o continue prospective evaluation of this 
device. The overall incidence of IVCT was 12% for all 
IVC filters in this study. Vena cava thrombosis oc- 
curred in 13.6% of all Greenfield filters, in 12.5% of 
cases in which a TGF was used, and in 17.5% of cases 
in which an SGF was placed. In the past it has been 
suspected that devices such as the BNF would be 
associated with a higher rate of IVC occlusion, 
because its design was regarded as inherently throm- 
bogenic. Previous studies have reported an IVC 
occlusion rate of 18.9% for the BNF. 4° In this series 
IVCT occurred in only 5.3% of cases after placement 
ofa BNF, but this rate was not significantly ower than 
that of any of the other filter groups. It could be 
argued that a lower rate of IVCT would be expected 
with the BNF, because the device was placed prefer- 
entially in vena cavae of larger diameter. Such a 
speculation can only reasonably be addressed by a 
randomized prospective comparison of these devices. 
The IVCT rate for the NF group in this study was 
12%, which is similar to the 14% reported previously 
by Simon et al.22 Overall in this study no significant 
difference was found in the incidence oflVCT among 
the different filter types. 
It should be noted that the thrombotic events 
observed in this study (IST and IVCT) were diag- 
nosed very early after insertion in most cases. It has 
been observed in the past that spontaneous lysis of 
insertion site and caval thrombi may subsequently 
occur. However, these latter events have not been 
prospectively studied and were not the focus of this 
report. The acquisition of late follow-up in patients 
having IVC filters is well known, because there is a 
high initial mortality rate (19.5% in this study) and a 
compromised late survival in many patients because of 
their associated medical problems (e. g., malignancy ). 
These observations may mal<e early thrombotic 
events clinically irrelevant, but this would not be the 
case, for example, in younger patients with trauma 
who would be expected to have a normal ife expec- 
tancy after ecovery from their injuries. It is clear that 
more information about the natural history of ob- 
served early IT and IVCT is necessary todetermine its 
overall clinical importance and its effect on lower limb 
venous dysfunction. 
This study confirms the liberalization of indica- 
tions for filter insertion that has occurred with the 
evolution ofpercutaneously p aced devices. Less than 
15% of patients had PE before filter placement, and 
more than 20% had a filter placed for prophylaxis 
before any diagnosed thromboembolic event had 
occurred. The issue of prophylactic filter placement 
has been controversial. This indication has been 
expanded in almost every series as it has become 
recognized that in certain high-risk patient groups 
(particularly patients with multitrauma) even stan- 
dard DVT prophylaxis may be ineffective. Febbe et 
al.4~ reported a prophylactic filter placement rate of 
46% of 59 patients with multiple medical and surgical 
problems. Ricco et al., 25 in a multicenter trial of 
patients with trauma, reported a 65% rate of filter 
insertion for prophylaxis. Rohrer et al.42 attempted to
identify specific groups of patients at risk for DVT and 
PE who did not have the traditional indications for 
filter placement but who would benefit from prophy- 
lactic filter insertion. These groups included patients 
with trauma who had extremity and concomitant 
abdominal and neurologic injuries. Todd et al. 4a and 
Myllynen et al.44 have proposed prophylactic filter 
placement inpatients with hip and pelvic fractures and 
spinal cord injuries. Rogers et al.20 identified patients 
with trauma at high risk for PE after performing a
retrospective chart review of all patients with a diag- 
nosis of pulmonary embolism. They identified four 
patient groups including age greater than 55 years 
with long bone fracture, severe head injury and coma, 
pelvic and long bone fractures, and spinal cord injury 
with paraplegia or quadriplegia. Rogers et al. 2° esti- 
mated that 5% of the trauma population meets this 
criteria and should be candidates for prophylactic 
filter insertion. 
Overall, filters placed for prophylaxis alone were 
used significantly more often in men than in women 
(26% vs 12.2%, p < 0.05). Most of the filters placed for 
prophylaxis were in the patients with trauma, and this 
finding probably reflects that fact that men make up a 
higher percentage ofpatients with trauma. No patient 
who had filter placement for prophylaxis had vena 
caval thrombosis during this study. The incidence of 
IVCT was 23.1% in patients who had filters placed for 
PE and 13.1% in cases with DVT as the indication for 
filter placement. The incidence of IVCT was signifi- 
cantly higher in the PE group than in patients with 
prophylactic filters (p < 0.004). It would seem logical 
that patients with the most serious thromboembolic 
complications (i.e., pulmonary embolism) might be 
more likely to either "trap" thrombus in the filter or 
that they have more severe thrombosis. Mthough 
prophylactic filter insertion carried a lower risk of 
WCT in this study, Harris et al.4S reported phlegmasia 
cerulea dolens in four patients who had prophylactic 
filter placement. They recommended anticoagulant 
therapy whenever possible after filter placement to 
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prevent this serious thrombotic complication. As 
noted previously, this study was not  controlled for 
anticoagulant use. IST developed in more than 14% of 
patients treated with prophylactic filters in this series. 
Because treatment thereafter was at the discretion of 
the managing physicians, the impact of anticoagulant 
therapy on the extension of these DVT and develop- 
ment  of more serious thrombotic omplications such 
as described by Harris et al. is uncertain. It remains to 
be more thoroughly documented by prospective 
studies what the true risks and benefits (and costs) of 
prophylactic filter insertion are in larger groups o f  
patients. 
This study documented a significant incidence of 
insertion site thrombosis (24.7%) and vcna caval 
thrombosis (12%) diagnosed by prospective duplex 
ultrasound scanning in patients having placement of 
an IVC filter. This patient group had a representative 
variety of clinical conditions een in an adult hospi- 
talized patient populat ion and a reasonably typical 
spectrum of indications for filter insertion. The oc- 
currence of these thrombotic omplications was not  
identifiably related to the type of filter used, the 
insertion site chosen, or the sex of the patient. An 
increasing incidence of both IST and IVCT was 
associated with more advanced thromboembol ic  
complications that were the indications for filter 
placement. This study would certainly suggest he 
need for and the utility of a prospective randomized 
comparison of devices currently available for vena 
caval interrupt ion to provide the most objective 
assessment 0fdifferent management  strategies and to 
allow clinicians amore rational means for selection of 
these devices in the future. 
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